2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on AML: Are Ivosidenib and Enasidenib Good Options to Be Added to the Backbone of HMAs?

115 views
July 22, 2020
Comments 0
Login to view comments. Click here to Login